BlackRock, Inc. 13D and 13G filings for Capricor Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Capricor Therapeutics, Inc. CAPR |
BlackRock Inc. BLK |
2,966,914 6.500% |
1,216,907 (+69.54%) |
Filing |
| 2024-11-12 11:46 am Unchanged |
2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR |
BlackRock Inc. BLK |
1,750,007 5.400% |
0 (Unchanged) |
Filing |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR |
BlackRock Inc. BLK |
1,750,007 5.400% |
1,750,007 (New Position) |
Filing |